臨床試験を検索:MEK 162療法または分子標的療法
合計5289件
-
Yale UniversityNational Cancer Institute (NCI)完了
-
Northwestern UniversityNational Cancer Institute (NCI)完了
-
Second Affiliated Hospital, School of Medicine,...Hebei Medical University Fourth Hospital; Zhejiang University; Cancer Hospital of The University...まだ募集していません切除不能な転移性結腸直腸がん
-
Second Affiliated Hospital of Nanchang UniversityNanchang Universityわからない
-
Zhejiang Cancer Hospital募集
-
M.D. Anderson Cancer CenterTempus AI積極的、募集していない
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable Funds完了
-
Fudan UniversityChanghai Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University; Ruijin...完了
-
Memorial Sloan Kettering Cancer CenterUniversity of Texas Southwestern Medical Center; Wake Forest University積極的、募集していない
-
Institut Curieわからない
-
Sierra Oncology LLC - a GSK company完了
-
University of Illinois at Chicago募集
-
Medical College of Wisconsinまだ募集していません
-
INSYS Therapeutics Inc完了
-
INSYS Therapeutics Inc完了多形性膠芽腫 | 悪性神経膠腫 | 退形成性星細胞腫 | 混合性乏星細胞腫 | 悪性星細胞腫アメリカ
-
INSYS Therapeutics Inc完了
-
Basilea PharmaceuticaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins終了しました
-
University of California, San DiegoNational Institutes of Health (NIH)まだ募集していません尿路感染症、再発
-
Northwestern University積極的、募集していない
-
Shanghai University of Traditional Chinese Medicineわからない
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完了
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)募集
-
Shanghai 10th People's Hospital募集
-
Henan Cancer HospitalKingbio Medical (Beijing) Co., Ltd.募集
-
Ruijin HospitalChongqing Kingbiotech Co.,Ltd募集
-
Henan Cancer HospitalKingbio Medical (Beijing) Co., Ltd.募集